Transcatheter Embolization and Occlusion Devices Market to Grow with the Increasing Number of Minimally Invasive Surgeries

 

Transcatheter Embolization and Occlusion Devices are used to obstruct blood flow in particular area of the body. These devices are also used to control or prevent abnormal bleeding, eliminate abnormal connections between arteries and veins, as well as to treat aneurysms, which refers to formation of a bulge or a sac in weak arterial wall. Thus, there is an increasing demand for minimally invasive surgeries compared to conventional open surgery across the globe, driving the growth of the transcatheter embolization and occlusion devices market. Embolization is a minimally invasive procedure that blocks one or more blood vessels.

Transcatheter embolization and occlusion devices are used to place synthetic materials or drugs through a catheter into a blood vessel to prevent blood flow to the area. Moreover, minimally invasive surgical procedures offer various advantages, such as reduced probability of errors, low blood loss, low surgical time, low recovery time, and others. This in turn is increasing the demand for transcatheter embolization and occlusion devices. For example, in November 2020, Append Medical completed transcatheter implant-free LAA occlusion procedures, intended to significantly simplify the goal of sealing the LAA and preventing stroke in atrial fibrillation (AF) patients without leaving any implant in the heart.

Furthermore, in June 2021, Abbott received CE mark approval for its Amplatzer Steerable Delivery Sheath for left atrial appendage (LAA) occlusion (closure) procedures to treat atrial fibrillation (AF) patients who are at increased risk of ischemic stroke. The minimally invasive device, which has also received approval from Health Canada, is indicated to be used along with Abbott’s Amplatzer Amulet LAA Occluder. This in turn is turn is also expected to propel the growth of the Transcatheter Embolization and Occlusion Devices Market, especially in North America and Europe. Embolization preserve normal blood flow in the surrounding regions to keep tissues healthy while dealing with problematic bleeding.

Transcatheter embolization is ideal for a wide range of gynecologic and obstetric abnormalities. Moreover, transcatheter embolization procedures decrease both morbidity and mortality, and preserve the patient’s future fertility. Transcatheter embolization and occlusion devices help avoid complications, such as catheter entrapment, imprecise deployment, and balloon deflation associated with coiling. Thus, physicians are increasingly using these devices to leverage on the benefits associated with them, which in turn is expected to accelerate the demand for such devices, driving the growth of the Transcatheter Embolization and Occlusion Devices Market growth across the globe.